Page last updated: 2024-11-05

trazodone and Hypermyotonia

trazodone has been researched along with Hypermyotonia in 1 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research Excerpts

ExcerptRelevanceReference
"42) taking trazodone (median dosage 50 mg/d, range 25-200 mg) for insomnia and 19 children (11 girls and 8 boys, mean age 13."1.72Trazodone affects periodic leg movements and chin muscle tone during sleep less than selective serotonin reuptake inhibitor antidepressants in children. ( Bruni, O; DelRosso, LM; Ferri, R; Fickenscher, A; Mogavero, MP; Schenck, CH, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
DelRosso, LM1
Mogavero, MP1
Bruni, O1
Schenck, CH1
Fickenscher, A1
Ferri, R1

Other Studies

1 other study available for trazodone and Hypermyotonia

ArticleYear
Trazodone affects periodic leg movements and chin muscle tone during sleep less than selective serotonin reuptake inhibitor antidepressants in children.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2022, 12-01, Volume: 18, Issue:12

    Topics: Antidepressive Agents; Child; Chin; Female; Humans; Leg; Male; Muscle Hypertonia; Muscle Hypotonia;

2022